Literature DB >> 10854220

Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.

H Kuster1, M Opravil, P Ott, E Schlaepfer, M Fischer, H F Günthard, R Lüthy, R Weber, R W Cone.   

Abstract

We report detailed quantitative analysis of human immunodeficiency virus-1 (HIV-1) p24 and HIV-1 RNA in tonsil biopsies from 13 patients with early, asymptomatic HIV infection before and during combination antiretroviral therapy. Using fluorescent microscopy in conjunction with reverse transcriptase-polymerase chain reaction of frozen tissue sections, we show that plasma and tissue viral loads decreased by approximately 3 logs during the 1-year treatment period, with good correlation between the HIV-1 p24 and HIV-1 RNA response in tissue. The decrease of tissue viral load was delayed compared to plasma viral load, possibly explained by the observation that the amount of follicular dendritic cell-associated virus correlated best with the area under the curve of plasma HIV-1 RNA throughout the last 12 weeks. Before and during treatment, the relative proportions of HIV-1 on follicular dendritic cells and within mononuclear cells remained constant, suggesting similar decay characteristics in these two lymphoid tissue compartments. However, viral p24 or RNA remained almost always detectable in tissue despite full suppression of HIV-1 RNA in plasma, and increased even after short-term rebounds in plasma viral load. Thus, full and sustained suppression of viral replication was required to efficiently decrease viral load in lymphoid tissue, but complete abolition of residual viral replication was not achieved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854220      PMCID: PMC1850084          DOI: 10.1016/S0002-9440(10)65070-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells.

Authors:  H K Parmentier; D van Wichen; D M Sie-Go; J Goudsmit; J C Borleffs; H J Schuurman
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy.

Authors:  P Biberfeld; K J Chayt; L M Marselle; G Biberfeld; R C Gallo; M E Harper
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

3.  Expression of HIV in lymph node cells of LAS patients. Immunohistology, in situ hybridization, and identification of target cells.

Authors:  C D Baroni; F Pezzella; M Pezzella; B Macchi; D Vitolo; S Uccini; L P Ruco
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

4.  Single copies of HIV proviral DNA detected by fluorescent in situ hybridization.

Authors:  J P Spadoro; H Payne; Y Lee; M J Rosenstraus
Journal:  Biotechniques       Date:  1990-08       Impact factor: 1.993

5.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Authors:  G Dornadula; H Zhang; B VanUitert; J Stern; L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; J DeSimone; R J Pomerantz
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

7.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.

Authors:  K Tenner-Racz; P Racz; M Bofill; A Schulz-Meyer; M Dietrich; P Kern; J Weber; A J Pinching; F Veronese-Dimarzo; M Popovic
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

8.  Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method.

Authors:  K Kure; W D Lyman; K M Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

9.  In situ hybridization of human immunodeficiency virus (HTLV-III) in cryostat sections of lymph nodes of lymphadenopathy syndrome patients.

Authors:  M Pezzella; F Pezzella; C Galli; B Macchi; P Verani; F Sorice; C D Baroni
Journal:  J Med Virol       Date:  1987-06       Impact factor: 2.327

10.  Subcellular localization of low-abundance human immunodeficiency virus nucleic acid sequences visualized by fluorescence in situ hybridization.

Authors:  J B Lawrence; L M Marselle; K S Byron; C V Johnson; J L Sullivan; R H Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more
  12 in total

1.  Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines.

Authors:  Jenna Rychert; Daryld Strick; Sue Bazner; James Robinson; Eric Rosenberg
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08-19       Impact factor: 2.205

2.  In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon.

Authors:  Giorgio Mangino; Zulema A Percario; Gianna Fiorucci; Gabriele Vaccari; Santiago Manrique; Giovanna Romeo; Maurizio Federico; Matthias Geyer; Elisabetta Affabris
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

3.  Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.

Authors:  Stefan Baenziger; Roxane Tussiwand; Erika Schlaepfer; Luca Mazzucchelli; Mathias Heikenwalder; Michael O Kurrer; Silvia Behnke; Joachim Frey; Annette Oxenius; Helen Joller; Adriano Aguzzi; Markus G Manz; Roberto F Speck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

4.  The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence.

Authors:  Steven A Yukl; Amandeep K Shergill; Terence Ho; Maudi Killian; Valerie Girling; Lorrie Epling; Peilin Li; Lisa K Wong; Pierre Crouch; Steven G Deeks; Diane V Havlir; Kenneth McQuaid; Elizabeth Sinclair; Joseph K Wong
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

5.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Authors:  Mikulas Popovic; Klara Tenner-Racz; Colleen Pelser; Hans-Jurgen Stellbrink; Jan van Lunzen; George Lewis; Vaniambadi S Kalyanaraman; Robert C Gallo; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.

Authors:  Ronald P van Rij; Janny A Visser; Rieneke M E van Praag; Ronald Rientsma; Jan M Prins; Joep M A Lange; Hanneke Schuitemaker
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 7.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

8.  The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load.

Authors:  Zhengguo Xiao; Laura Batista; Scott Dee; Patrick Halbur; Michael P Murtaugh
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Exogenous HIV-1 Nef upsets the IFN-γ-induced impairment of human intestinal epithelial integrity.

Authors:  Maria Giovanna Quaranta; Olimpia Vincentini; Cristina Felli; Francesca Spadaro; Marco Silano; Diego Moricoli; Luciana Giordani; Marina Viora
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

10.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.